CCCC - C4 Therapeutics, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 6.16

Open

$ 6.82

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 6.16 - $ 6.90

52 Week Range

$ 1.06 - $ 11.88

Volume

1,457,648

Average Volume

Market Cap

421.54M

Beta (5Y Monthly)

$ 2.31

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-08-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-01-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-11-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-11-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Key Takeaways From C4 Therapeutics Analyst...
05/09/2024 18:01:07

Wells Fargo Maintains Equal-Weight on C4 T...
05/09/2024 15:58:31

Wells Fargo analyst Derek Archila maintains C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight and raises the price target fr...

Stifel Maintains Buy on C4 Therapeutics, R...
05/09/2024 13:57:15

Stifel analyst Bradley Canino maintains C4 Therapeutics (NASDAQ:CCCC) with a Buy and raises the price target from $13 to $14.

C4 Therapeutics' Cash, Cash Equivalents an...
05/08/2024 11:26:24

C4 Therapeutics Q1 2024 GAAP EPS $(0.41) B...
05/08/2024 11:25:11

C4 Therapeutics Presents New Preclinical D...
04/08/2024 12:25:57

C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein d...

C4 Therapeutics To Present New Preclinical...
03/05/2024 21:35:47

C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein d...

C4 Therapeutics shares are trading higher ...
03/04/2024 14:24:49

C4 Therapeutics Has Entered Into A License...
03/04/2024 12:05:55

Breaking Down C4 Therapeutics: 4 Analysts ...
02/26/2024 16:00:42

Morgan Stanley Maintains Equal-Weight on C...
02/26/2024 15:42:36

Morgan Stanley analyst Terence Flynn maintains C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight and raises the price target...

C4 Therapeutics' Cash, Cash Equivalents An...
02/22/2024 12:21:10

C4 Therapeutics FY EPS $(2.67) Down From $...
02/22/2024 12:19:50

C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(2.67) per share. This is a 1.91 percent decrease over losses of $(...

capital-one-financial-to-acquire-discover-joins-ssr-mining-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Capital One Financial To Acquire Discover,...
02/20/2024 10:11:55

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday.

Analyst Expectations For C4 Therapeutics's...
01/29/2024 12:00:32

JP Morgan Upgrades C4 Therapeutics to Neut...
01/29/2024 10:45:12

JP Morgan analyst Eric Joseph upgrades C4 Therapeutics (NASDAQ:CCCC) from Underweight to Neutral and announces $6 price target.

C4 Therapeutics Announces 2024 Priorities;...
01/09/2024 21:04:32

Multiple 2024 Clinical Updates Expected, Including Data from the Ongoing CFT7455 and CFT1946 Phase 1 Dose Escalation Trials Pri...

RA Capital Management Reports 9.9% Passive...
12/26/2023 21:39:27

-SEC Filing

C4 Therapeutics 13G Filing Shows Commodore...
12/22/2023 21:28:26

- SEC Filing

What's Going On With C4 Therapeutics Stock?
12/15/2023 17:00:27

C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past fi...